---
title: "CLARKSON JOHN G — Ownership Dossier"
canonical: https://whiteintel.dev/entity/db13dfe0-526a-524f-8453-cd74993843fb
json: https://whiteintel.dev/api/public/dossier/db13dfe0-526a-524f-8453-cd74993843fb
identifier: sec:0001224094
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CLARKSON JOHN G

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001224094`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/db13dfe0-526a-524f-8453-cd74993843fb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/db13dfe0-526a-524f-8453-cd74993843fb  

## Ownership & control

### Holdings / subsidiaries

- **NOVEN PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/1dcf1857-d20d-5349-a578-f83cfef10f22

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CLARKSON JOHN G**. Human view: https://whiteintel.dev/entity/db13dfe0-526a-524f-8453-cd74993843fb · Structured JSON: https://whiteintel.dev/api/public/dossier/db13dfe0-526a-524f-8453-cd74993843fb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._